TR200001147T2 - Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı - Google Patents
Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımıInfo
- Publication number
- TR200001147T2 TR200001147T2 TR2000/01147T TR200001147T TR200001147T2 TR 200001147 T2 TR200001147 T2 TR 200001147T2 TR 2000/01147 T TR2000/01147 T TR 2000/01147T TR 200001147 T TR200001147 T TR 200001147T TR 200001147 T2 TR200001147 T2 TR 200001147T2
- Authority
- TR
- Turkey
- Prior art keywords
- macular degeneration
- macrolides
- cancer
- treatment
- compound
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 208000002780 macular degeneration Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 229940041033 macrolides Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96147397A | 1997-10-31 | 1997-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200001147T2 true TR200001147T2 (tr) | 2000-08-21 |
Family
ID=25504514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/01147T TR200001147T2 (tr) | 1997-10-31 | 1998-10-30 | Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1027060A2 (sk) |
| JP (1) | JP2001521891A (sk) |
| KR (1) | KR20010031577A (sk) |
| CN (1) | CN1278178A (sk) |
| AR (1) | AR043071A1 (sk) |
| AU (1) | AU1206799A (sk) |
| BG (1) | BG104436A (sk) |
| BR (1) | BR9813318A (sk) |
| CA (1) | CA2307850A1 (sk) |
| HU (1) | HUP0100012A3 (sk) |
| IL (1) | IL135518A0 (sk) |
| NO (1) | NO20002189L (sk) |
| PL (1) | PL340604A1 (sk) |
| SK (1) | SK6172000A3 (sk) |
| TR (1) | TR200001147T2 (sk) |
| WO (1) | WO1999022722A2 (sk) |
| ZA (1) | ZA989885B (sk) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001079520A1 (en) | 2000-04-13 | 2001-10-25 | Biotica Technology Limited | Hybrid glycosylated products and their production and use |
| JP2006511475A (ja) | 2002-09-18 | 2006-04-06 | トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア | 脈絡膜新生血管症の抑制方法 |
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| JP4719671B2 (ja) | 2003-03-28 | 2011-07-06 | コーネル・リサーチ・ファンデーション・インコーポレイテッド | ミグラスタチンアナログ組成物およびその使用 |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| WO2005027906A1 (en) | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
| US7087237B2 (en) * | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| CN1950388A (zh) * | 2004-02-27 | 2007-04-18 | 瑞伯-X医药品有限公司 | 大环化合物以及其制作和使用方法 |
| JP5383037B2 (ja) * | 2004-02-27 | 2014-01-08 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | 大環状化合物およびそれらを製造し使用する方法 |
| JP5149001B2 (ja) | 2004-05-25 | 2013-02-20 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | 癌の処置におけるマイグラスタチンアナログ |
| EP1805161B1 (en) | 2004-09-23 | 2014-05-07 | Sloan-Kettering Institute For Cancer Research | Isomigrastatin analogs in the treatment of cancer |
| GB2438544A (en) | 2005-02-09 | 2007-11-28 | Cooper Internat Corp | Liquid formulations for treatment of diseases or conditions |
| PL1904056T3 (pl) | 2005-07-18 | 2009-09-30 | Minu Llc | Zastosowanie makrolidu do przywracania czucia rogówkowego |
| EP1934237A2 (en) | 2005-08-24 | 2008-06-25 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| EP1928893A2 (en) | 2005-08-24 | 2008-06-11 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| CA2635797C (en) | 2006-02-09 | 2015-03-31 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| CN101443004B (zh) | 2006-03-23 | 2013-03-06 | 参天制药株式会社 | 用于与血管通透性有关的疾病或病症的制剂 |
| CN106317146B (zh) * | 2015-06-18 | 2019-06-21 | 沈阳药科大学 | 双环克拉霉素衍生物及其作为肿瘤细胞增值抑制剂的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6461090A (en) * | 1989-10-30 | 1991-05-02 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
| US5498424A (en) * | 1994-11-30 | 1996-03-12 | Klein; Ira | Method of treating obesity |
-
1998
- 1998-10-29 ZA ZA989885A patent/ZA989885B/xx unknown
- 1998-10-29 AR ARP980105434A patent/AR043071A1/es unknown
- 1998-10-30 SK SK617-2000A patent/SK6172000A3/sk unknown
- 1998-10-30 CN CN98810825A patent/CN1278178A/zh active Pending
- 1998-10-30 BR BR9813318-7A patent/BR9813318A/pt not_active Application Discontinuation
- 1998-10-30 CA CA002307850A patent/CA2307850A1/en not_active Abandoned
- 1998-10-30 TR TR2000/01147T patent/TR200001147T2/xx unknown
- 1998-10-30 HU HU0100012A patent/HUP0100012A3/hu unknown
- 1998-10-30 KR KR1020007004625A patent/KR20010031577A/ko not_active Ceased
- 1998-10-30 PL PL98340604A patent/PL340604A1/xx unknown
- 1998-10-30 WO PCT/US1998/023043 patent/WO1999022722A2/en not_active Ceased
- 1998-10-30 IL IL13551898A patent/IL135518A0/xx unknown
- 1998-10-30 AU AU12067/99A patent/AU1206799A/en not_active Abandoned
- 1998-10-30 JP JP2000518656A patent/JP2001521891A/ja not_active Withdrawn
- 1998-10-30 EP EP98955206A patent/EP1027060A2/en not_active Withdrawn
-
2000
- 2000-04-27 NO NO20002189A patent/NO20002189L/no unknown
- 2000-05-15 BG BG104436A patent/BG104436A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999022722A3 (en) | 1999-08-05 |
| BG104436A (en) | 2000-12-29 |
| HUP0100012A3 (en) | 2003-07-28 |
| SK6172000A3 (en) | 2001-03-12 |
| CN1278178A (zh) | 2000-12-27 |
| BR9813318A (pt) | 2000-08-22 |
| NO20002189L (no) | 2000-06-28 |
| PL340604A1 (en) | 2001-02-12 |
| CA2307850A1 (en) | 1999-05-14 |
| IL135518A0 (en) | 2001-05-20 |
| ZA989885B (en) | 1999-05-05 |
| EP1027060A2 (en) | 2000-08-16 |
| JP2001521891A (ja) | 2001-11-13 |
| WO1999022722A2 (en) | 1999-05-14 |
| KR20010031577A (ko) | 2001-04-16 |
| AR043071A1 (es) | 2005-07-20 |
| NO20002189D0 (no) | 2000-04-27 |
| HUP0100012A2 (hu) | 2001-05-28 |
| AU1206799A (en) | 1999-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200001147T2 (tr) | Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı | |
| ATE235893T1 (de) | Orale zubereitung enthaltend zonula occludens toxin und einen biologisch aktiven wirkstoff sowie deren verwendung | |
| MY129809A (en) | Quinazoline derivatives | |
| HUP0001170A3 (en) | Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer | |
| DK0490077T3 (da) | Antisense-oligonukleotider til behandling af cancer | |
| AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
| GEP20033025B (en) | 4,4-Biarylpiperidine Derivatives with Opioid Receptor Activity | |
| GEP20063895B (en) | Platinum derivative pharmaceutical formulations | |
| HUP9900905A2 (hu) | D4-Vitamin származékok alkalmazása rák kezelésére szolgáló gyógyászati készítmények előállítására | |
| EE9900450A (et) | Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine | |
| DE69905384D1 (de) | Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs | |
| UA48958C2 (uk) | 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі | |
| TR199801732T2 (xx) | Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri. | |
| ATE264309T1 (de) | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren | |
| TW374085B (en) | Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use | |
| PL318130A1 (en) | Terpenod derivatives (of sarcodictyine)as antineoplastic agents | |
| DE69334087D1 (de) | Arzneimittelzusammensetzung enthaltend TCF-II | |
| GB9505082D0 (en) | Medicament | |
| MX9702671A (es) | Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados. | |
| ATE215941T1 (de) | Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| ATE106732T1 (de) | Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung. | |
| MY133596A (en) | Compound and method for the treatment of pain | |
| ATE329613T1 (de) | Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas | |
| IT1271292B (it) | Composizioni farmaceutiche contenenti melatonina e inibitori dei recettori degli estrogeni |